These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37921511)

  • 1. TRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmune Encephalomyelitis.
    Lu Y; Chiang J; Zhang R; Roche PA; Hodes RJ
    J Immunol; 2023 Dec; 211(12):1814-1822. PubMed ID: 37921511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
    Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
    Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
    Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
    J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis.
    Aarts SA; Seijkens TT; Kusters PJ; van Tiel CM; Reiche ME; den Toom M; Beckers L; van Roomen CP; de Winther MP; Kooij G; Lutgens E
    J Pathol; 2019 Apr; 247(4):471-480. PubMed ID: 30471110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals.
    Yasui T; Muraoka M; Takaoka-Shichijo Y; Ishida I; Takegahara N; Uchida J; Kumanogoh A; Suematsu S; Suzuki M; Kikutani H
    Int Immunol; 2002 Mar; 14(3):319-29. PubMed ID: 11867568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
    Kalantari T; Karimi MH; Ciric B; Yan Y; Rostami A; Kamali-Sarvestani E
    Clin Exp Immunol; 2014 May; 176(2):180-9. PubMed ID: 24387596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.
    Woolaver RA; Wang X; Dollin Y; Xie P; Wang JH; Chen Z
    J Immunol; 2018 Dec; 201(11):3421-3430. PubMed ID: 30341187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF6 is a critical regulator of LMP1 functions in vivo.
    Arcipowski KM; Stunz LL; Bishop GA
    Int Immunol; 2014 Mar; 26(3):149-58. PubMed ID: 24170780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
    Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
    J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
    Graham JP; Moore CR; Bishop GA
    J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.
    Lu LF; Ahonen CL; Lind EF; Raman VS; Cook WJ; Lin LL; Noelle RJ
    Blood; 2007 Jul; 110(1):193-200. PubMed ID: 17360936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 Upregulation in the Retina of Patients With Diabetic Retinopathy: Association With TRAF2/TRAF6 Upregulation and Inflammatory Molecule Expression.
    Vos S; Aaron R; Weng M; Daw J; Rodriguez-Rivera E; Subauste CS
    Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):17. PubMed ID: 37294707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
    Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
    J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.